

Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1280, 2009-01, pp. : 30-30
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Interferon-β-1a: First report of pulmonary arterial hypertension: case report
Reactions Weekly, Vol. 1, Iss. 1307, 2010-01 ,pp. :


Infliximab: First report of Crohn's disease: case report
Reactions Weekly, Vol. 1, Iss. 1155, 2007-01 ,pp. :




Interferon--1a: First report of dermatomyositis: case report
Reactions Weekly, Vol. 1, Iss. 1227, 2008-01 ,pp. :


Interferon/peginterferon-α-2b/ribavirin: First report of Crohn's disease: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1063, 2005-01 ,pp. :